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Decreased effectiveness of bones' adaptive response to mechanical loading contributes to age-related bone loss.
In young mice, intermittent administration of parathyroid hormone (iPTH) at 20–80 μg/kg/day interacts syner-
gisticallywith artiﬁcially applied loading to increase bonemass. Herewe report investigations on the effect of dif-
ferent doses and duration of iPTH treatment on mice whose osteogenic response to artiﬁcial loading is impaired
by age. One group of aged, 19-month-old female C57BL/6 mice was given 0, 25, 50 or 100 μg/kg/day iPTH for
4 weeks. Histological and μCT analysis of their tibiae revealed potent iPTH dose-related increases in
periosteally-enclosed area, cortical area and porosity with decreased cortical thickness. There was practically
no effect on trabecular bone. Another group was given a submaximal dose of 50 μg/kg/day iPTH or vehicle for
2 or 6 weeks with loading of their right tibia three times per week for the ﬁnal 2 weeks. In the trabecular bone
of thesemice the loading-related increase in BV/TVwas abrogated by iPTH primarily by reduction of the increase
in trabecular number. In their cortical bone, iPTH treatment time-dependently increased cortical porosity. Load-
ing partially reduced this effect. The osteogenic effects of iPTH and loading on periosteally-enclosed area and cor-
tical area were additive but not synergistic. Thus in aged, unlike young mice, iPTH and loading appear to have
separate effects. iPTH alone causes a marked increase in cortical porosity which loading reduces. Both iPTH and
loading have positive effects on cortical periosteal bone formation but these are additive rather than synergistic.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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1. Introduction
Throughout life, bones adapt their architecture to ensure that they
are sufﬁciently robust to withstand the habitual levels of mechanical
loading to which they are subjected without accumulation of excessive
microdamage, or sustaining fracture. This functional adaptation,
achieved by the processes of modelling and remodelling in response
to the local strain environment engendered by loading, is commonly re-
ferred to as the “mechanostat” [1].With increasing age there is failure to
maintain the balance between formation and resorption with resulting
progressive net bone loss [2]. Previous studies by ourselves and others
have documented that bone's adaptive responsive to anabolic stimula-
tion bymechanical loading is impaired in agedmice [3–6]. It is probable
that this reduced ability to respond appropriately to mechanical
stimulation is a major contributor to the pathogenesis of age-related
bone loss [7].
Pharmacotherapy targeted at enhancing agedbones response tome-
chanical loading should therefore have the potential to prevent some of
the deleterious effects of ageing on bone and restore functionally-
relevant structure. Intermittent administration of parathyroid hormone
(iPTH)was, until recently, the only licensed anabolic treatment for oste-
oporosis [8].
The mechanism of action of PTH has been extensively studied in
mice and other experimental models. PTH acts predominantly through
its receptor, PTH1R. Previous studies have investigated both
tamoxifen-inducible targeted deletion of PTH1R and constitutively ac-
tive PTH receptor (caPTH1R) in osteocytes using a Dmp1-Cre. Deletion
of PTH1R in osteocytes results in loss of both cortical and trabecular
bone [9] although a further study documented conﬂicting results with
a high bonemass phenotype [10]. Conversely, mice expressing caPTH1R
in osteocytes had dramatically increased bonemass, but onlywhen they
also expressed the Wnt co-receptor LRP5 [11]. Furthermore, the
caPTHR1 transgenic mice demonstrated greatly reduced Sost expres-
sion, the gene encoding sclerostin protein which negatively regulates
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Wnt signalling via LRP co-receptors. An additional study using Sost
overexpressing and knockout mice indicated that reduction of
sclerostin appears to contribute to some extent to the anabolic effect
of PTH [12]. Sclerostin down regulation is also a necessary step in
bone's anabolic response to mechanical stimulation [13] suggesting
some commonality between themechanisms of action of iPTH andme-
chanical stimulation.
A previous study from our laboratory demonstrated that combining
iPTH and mechanical loading caused a far greater anabolic response
than would have been expected from the response to either treatment
alone in both cortical and trabecular bone compartments of the mouse
tibia [14]. Therefore, we hypothesized that iPTH would have the poten-
tial to “sensitize” agedbone to the anabolic effects ofmechanical loading
and “rescue” its impaired adaptive response. However, to our knowl-
edge, this interaction has only been studied in young female mice that
have not yet displayed any age-related bone changes.
Although the effects of iPTH have been extensively studied, to our
knowledge there are no studies showing the effect of different doses
or duration of iPTH treatment in aged mice. Because different studies
have used different doses and duration of treatment, it is difﬁcult to
compare the results presented by different groups. Thus, in this study,
we aimed to determine the effect of different doses and duration of
treatment with iPTH alone and the effect of iPTH on the response of
aged bone to mechanical loading.
2. Materials and methods
2.1. Animals
Nineteen-month-old female C57BL/6 mice were obtained from
Charles River Inc. (Margate, UK). All mice were allowed free access to
water and a maintenance diet containing 0.75% calcium (EURodent
Diet 22%; PMI Nutrition International, LLC, Brentwood, MO, USA) in a
12-h light/dark cycle, with room temperature at 21 ± 2 °C. All cages
contained wood shavings, bedding and a cardboard tube for environ-
mental enrichment. Female mice were housed in groups of up to ﬁve
animals [15]. All procedures complied with the UK Animals (Scientiﬁc
Procedures) Act 1986 and were reviewed and approved by the Univer-
sity of Bristol ethics committee (Bristol, UK).
2.2. Dose-response study
Micewere divided into 4 weight matched groups (n= 8 per group)
and treated with either vehicle (0.9% saline) or PTH (1–34, Cat. No H-
4835, Bachem Biosciences, Switzerland) by daily subcutaneous injec-
tion. PTH was administered at 25, 50 or 100 μg/kg/day in 0.9% saline.
All mice were treated for 28 days and then sacriﬁced (Fig. 1a). The left
tibia was used for μCT scanning and the right hind limb for strain gaging
(see ex vivo strain measurements).
2.3. Ex vivo strain measurements
To apply similar magnitudes of peak strain to all groups of mice, we
ﬁrst established the load:strain relationship. In each mouse, a single el-
ement strain gage (EA-06-015DJ-120, Vishay Measurement Group, NC)
was bonded longitudinally to the medial aspect of the tibia at 37% of its
length from the proximal end. This is the site where we have previously
observed the greatest osteogenic response to axial loading [14,16–18].
Strains were measured across a range of peak loads between 3 and
19 N, applied using the same electromagnetic loading machine used
for in vivo loading (ElectroForce 3100; Bose Co., Eden Prairie, MN, USA).
2.4. Loading studies
Micewere treatedwith either vehicle or 50 μg/kg/day PTH (1–34) by
daily subcutaneous injection. Mice were injected daily for 15 or 40 days
for the 2-week (N= 7 and N= 6 for vehicle and iPTH treated mice re-
spectively) and 6-week (N= 13 and N= 13 for vehicle and iPTH treat-
ed mice respectively) studies respectively. The right tibiae were
subjected to external mechanical loading under isoﬂurane-induced an-
esthesia three times per week for two weeks starting from day 3 or 29
for the 2-week- and 6-week studies respectively. Left limbs were used
as internal controls as previously validated (Fig. 1b-c) [16,19]. The pro-
tocol for non-invasive loading of themouse tibia has been reported pre-
viously [16,20,21]. The ﬂexed knee and ankle joints are positioned in
concave cups; the upper cup containing the knee, is attached to an actu-
ator arm of the loading device and the lower cup to a dynamic load cell.
The tibia is held in place by a 0.5 N continuous static pre-load. 40 cycles
of dynamic load are superimposedwith 10s rest intervals between each
cycle. The protocol for one cycle consists of loading to the target strain
(measured on the medial aspect of the tibia at the 37% site from the
proximal end), hold for 0.05 s at the peak strain, and unloading back
to the 0.5 N pre-load. From the strain gage data (see “ex vivo strainmea-
surements”), there was no signiﬁcant difference between vehicle and
PTH-treated mice after 29 days of treatment in the 6-week loading
study. Therefore the same dynamic load of 12.6 N and load rate of
216 Ns−1 was applied to both groups of mice in the 6-week loading
study.
2.5. High-resolution μCT analysis
Following sacriﬁce, lower legs were ﬁxed in 4% PFA for 48 h at 4 °C
and then stored in 70% ethanol and whole tibiae imaged using the
SkyScan 1172 (Bruker, Kontich, Belgium) with a voxel size of 4.8 μm
(110 μm3). The scanning, reconstruction and method of analysis have
been previously reported [15,22]. We evaluated the effect of iPTH on
both tibiae and changes due to loading in bone volume fraction (BV/
TV), trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabec-
ular separation (Tb.Sp) in the trabecular region (0.25–0.75mmdistal to
the proximal physis) and cortical bone area (Ct.Ar), total cross-sectional
area inside the periosteal envelope (Tt.Ar), cortical thickness (Ct.Th)
and total cortical porosity (Ct.Po) at the cortical site (37% from the prox-
imal end), according to ASBMR guidelines [23]. Previously-validated,
freely available site-speciﬁcity software was used to analyze whole
bones and allow comparisons of the effects of treatment across all
sites in the bone as previously reported [18].
2.6. Fluorescent bone labelling
Fluorochrome labels were administered twice; calcein on day 1 and
alizarin on day 40 (the ﬁnal loading and treatment day). After μCT scan-
ning, tibiae from the pilot study were either embedded for histology
(next section) or ﬁxed in Bürckhardt's ﬁxative, dehydrated in increasing
concentrations of EtOH, and embedded in plastic (L RWhite Resin; Agar
Scientiﬁc, Stanstead, UK) for imaging of ﬂuorescent bone labels. Trans-
verse sections of 200 μm thickness sections were obtained for imaging
on a confocal microscope using FITC and TRITC ﬁlters for calcein and
alizarin respectively. Sectioning and imaging were performed at
Pharmatest Services Ltd. (Turku, Finland).
2.7. Immunohistochemistry
Remaining tibiaewere decalciﬁed for 21 days in 14% EDTAwith con-
tinuous agitation. The solution was changed three times per week and
adequate decalciﬁcation conﬁrmed by imaging using μCT and compar-
ing the bone density with surrounding muscle. Bones were then proc-
essed for histology and wax embedded and sectioned transversely
with 6 μm thickness. Sections corresponding to the 37% site of the
tibia (measured from the proximal end and where bone formation fol-
lowing mechanical loading is maximal [14,16,17]) were stained using
a standard H&E staining protocol or using the sclerostin, periostin or
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cathepsin K immunostaining protocol. These were as previously de-
scribed [24–26]. In short, the sections were deparafﬁnised with xylene
and rehydrated in decreasing concentrations of ethanol. Peroxidase ac-
tivity was blocked with hydrogen peroxide and unspeciﬁc binding was
blocked by normal rabbit or goat serum before incubation with the pri-
mary antibody; cathepsin K antibody (1 h incubation at room tempera-
ture, kindly provided as a gift from Professor Göran Andersson,
Karolinska Institutet), periostin antibody (incubated over night at 4 °C,
Abcam, rabbit anti-mouse/human Periostin ab14041) or sclerostin anti-
body (incubated over night at 4 °C, R&D systems Inc., goat anti mouse
Sost AF1589). For the cathepsin K and periostin assays, a goat anti-
rabbit secondary antibody (DAKO, #0432) was used; a rabbit anti-
goat antibody (Dako, E0466) was used for the sclerostin assay. The sig-
nalwas ampliﬁed using the vectastain Elite kit (PK 6100, Vector lab) and
visualized with DAB (Vector lab, ImmPACT DAB kit SK4100). Sclerostin
staining in the ﬁbula was quantiﬁed by measuring osteocyte sclerostin
stain intensity and binarizing to positive or negative staining using a
grayscale cut off of 170. The ﬁbula was analysed as this bone did not de-
velop dramatic pores which precluded analysis of osteocyte staining in
the tibia.
2.8. Statistical analysis
Data is presented as mean ± SEM. The effect of load on the strain
measurement was assessed using linear regression. The effect loading
on tibial length was assessed by paired samples t-test. The effect of
iPTH on measures of bone mass and architecture was assessed using a
one-way ANOVA with post-hoc Bonferroni correction. The effect of
loading and iPTH on measures of bone mass and architecture within
the two- and six-week experiment was assessed separately using two-
way repeated measures ANOVAs to account for the left and right
limbs being paired within each mouse. The effect of iPTH or vehicle on
sclerostin expression in the ﬁbula was assessed using an independent
samples t-test.
Statistical comparison of Site Speciﬁcity analyses was by mixed
model analysiswith bone site as aﬁxed categorical parameter, the inter-
vention (loading, PTH) as a ﬁxed effect and an intervention by site inter-
action to account for site-speciﬁc responses. Mouse IDwas included as a
random effect.When the effect of the interventionwas signiﬁcant over-
all, a post-hoc Bonferroni correction was applied to identify the individ-
ual sites atwhich the effectwas signiﬁcant at p b 0.05. All statisticswere
performed using SPSS for Windows (version 23, IBM, Chicago).
3. Results
Bodyweights and tibial lengths did not change signiﬁcantly in any
group over the course of the study: There was an average 0.5% loss of
bodyweight over 28 days in the pilot dose response study (p = 0.63),
a 2.5% loss over the 17 days in the 2-week study (p = 0.31), and a
1.1% loss over 40 days in the 6-week study (p = 0.07). PTH treatment
had no signiﬁcant effect on tibial length in either the pilot dose response
(p = 0.54), the 2-week (p = 0.22) or in the 6-week study (p = 0.54).
Loading had no effect on tibial length in the 2-week (p = 0.52) or the
6-week study (p = 0.15).
3.1. The effect of iPTH dose on trabecular and cortical bone in the tibia
In trabecular bone, there was no clear dose-response effect for any
dose of iPTH on any of the measured parameters (see Fig. 2a–d). There
was an isolated signiﬁcant effect of iPTHdose on Tb.Sp due to a signiﬁcant
increase in Tb.Spwith 50 μg/kg/day compared to vehicle (Fig. 2d). In con-
trast to the small effect of iPTH dose on trabecular bone, in cortical bone
the responsewas pronounced and followed a clear dose-response pattern
(Fig. 2e–i). Tt.Ar dose-dependently increased with iPTH (p b 0.001,
Fig. 2e) suggesting periosteal expansion. Ct.Ar also dose-dependently in-
creased (p b 0.01, Fig. 2f), although only with the 100 μg/kg/day dose
was a signiﬁcant difference observed from vehicle in post-hoc compari-
sons. There was no signiﬁcant effect of iPTH dose on Ma.Ar (p = 0.61).
iPTH dose-dependently reduced Ct.Th (p b 0.001, Fig. 2g). This occurred
due to the formation of intra-cortical pores as indicated by a dose-
dependent increase in total porosity (Ct.Po) (p b 0.001, Fig. 2h).
3.2. iPTH induces porosity due to intracortical osteoclastic bone resorption
Examination of ﬂuorescent labels indicated the intra-cortical pore
formation identiﬁed on μCT (Fig. 3a) was a dynamic process that oc-
curred within the study period during which iPTH was administered
(Fig. 3b). Sections of tibial cortex from the 37% site were also stained
using H&E in addition to immunohistochemical stains for cathepsin K,
sclerostin and periostin. The H&E stain revealed the intracortical pores
to contain large multinucleated cells with the features of osteoclasts
(Fig. 3c) that stained positive for cathepsin K (Fig. 3d). This process
was visible, although not so dramatic, after two weeks of iPTH treat-
ment. Two and six weeks of iPTH treatment resulted in a decrease in
the number of osteocytes staining positive for sclerostin (Fig. 3e). Quan-
tiﬁcation of osteocytic sclerostin staining in the ﬁbula demonstrated
Fig. 1. Timeline of experiments. a) In the dose response studymicewere injectedwith 0, 25, 50 or 100 μg/kg/day by subcutaneous injection for 28 days and killed on day 29. For the loading
studies, mice were injected with vehicle or 50 μg/kg/day for either b) 15 or c) 40 days with loading three times per week for the ﬁnal two weeks.
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that this decrease was statistically signiﬁcant (vehicle 49± 7%, iPTH 29
± 4%, p= 0.03, Supplementary Fig. 1). Periostin immunohistochemical
staining documented strongly positive cells within the intracortical
pores (Fig. 3f) which, combined with the ﬂuorescent images, is highly
suggestive of a dynamic remodelling process in response to iPTH involv-
ing osteoclastic bone resorption and osteoblastic bone formation.
3.3. Ex vivo strain gaging
To determine whether treatment with 50 μg/kg/day iPTH for 4 weeks
altered the load:strain relationship, strain gageswere attached to theme-
dial surface of the right tibia at the 37% site. Applying various loads to the
tibiae andmeasuring strain revealed a clear linear relationship. The gradi-
ent of both regression lines was signiﬁcantly different from zero (p b
0.001). There was no signiﬁcant difference between the strains engen-
dered by loading when the vehicle and iPTH-treated bones were com-
pared (p = 0.92, Fig. 4). Linear regression analysis allowed calculation
of the loads required to apply 1800 με (11.8 N) and 1750 με (12.6 N) at
the start of the 2-week- and 6-week studies respectively.
3.4. The effect of duration of iPTH treatment on trabecular bone; reversal of
the effect of mechanical loading on trabecular bone in the proximal tibia
In trabecular bone, there was a signiﬁcant interaction between the
effects of iPTH and mechanical loading on BV/TV, both in the 2-week
and 6-week studies (Fig. 5a). In both experiments, BV/TV was signiﬁ-
cantly increased by 2 weeks of mechanical loading in vehicle-treated
mice (+84% and +77% respectively), but this effect was abrogated by
treatment with iPTH (Fig. 5a). Loading increased Tb.Th in the two ex-
periments (+22% and +15% respectively). While 2-week iPTH treat-
ment had no signiﬁcant effect on Tb.Th, 6-week treatment with iPTH
signiﬁcantly decreased Tb.Th (−22%, p b 0.001), with no signiﬁcant in-
teraction in either study (Fig. 5b). The loading induced increase in Tb.N
(+52% and +62% for the two experiments respectively, Fig. 5c) was
depleted with concurrent iPTH treatment although there was no signif-
icant effect of iPTH or interaction. A signiﬁcant interaction was also de-
tected between loading and iPTH on Tb.N when the mice were pre-
treated with iPTH for four weeks prior loading. There was no effect of
loading or iPTH on Tb.Sp (Fig. 5d).
3.5. The effect of duration of iPTH treatment and loading on cortical bone
were additive
In cortical bone, loading alone increased Tt.Ar in the two- but not six-
week experiment (Fig. 6a). As expected from the pilot dose-response
study, iPTH increased Tt.Ar in the two- and six-week study (p = 0.01,
Fig. 6a). Loading alone increased Ct.Ar (5% and 6% respectively, Fig.
6b), although this was only signiﬁcant in the six-week experiment (P
b 0.001). Ct.Ar was signiﬁcantly increased by iPTH treatment in both ex-
periments (+18% and +13% for the two- and six-week studies
Fig. 2. The effect of various doses of iPTH on trabecular and cortical bone mass and architecture after 28 days of treatment. Mice were administered 0, 25, 50 or 100 μg/kg/day and bone
analysed by μCT. iPTH had no clear dose response effect on trabecular BV/TV (a), Tb.Th (b) or Tb.N (c) but did cause mild variation in Tb.Sp (d). Conversely therewas a marked increase in
Tt.Ar (e), Ct.Ar (f) and Ct.Po (h) with a corresponding decrease in Ct.Th (g) as shown in representative images (i). Analysis was by one-way ANOVAwith p-values indicated on the graphs.
Where signiﬁcant, post-hoc Bonferroni was performed. Bars with the same letter above were not signiﬁcantly different from each other.
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respectively), although there was no interaction between loading and
iPTH treatment in either study. Two weeks of concurrent iPTH treat-
ment did not affect Ct.Th (Fig. 6c), but six weeks iPTH treatment lead
to a large decrease in Ct.Th (p b 0.001) while loading caused a mild,
but signiﬁcant, increase (Fig. 6c). Two weeks of iPTH treatment in-
creased Ct.Po by 1.5-fold, while a further four weeks of iPTH treatment
with iPTH caused a dramatic increase in Ct.Po (2.5-fold),whichwas par-
tially decreased by mechanical loading (Fig. 6d). There was no signiﬁ-
cant interaction detected between iPTH and mechanical loading for
any of the measured cortical parameters suggesting the combined ef-
fects were additive or independent rather than synergistic.
3.6. The additive effects of iPTH and loadingwere observed across the length
of the tibia
A unique feature of mechanical loading as an osteoanabolic stimulus
is its ability to target bone formation to functionally relevant sites. Sys-
temic treatments such as PTHwhich interact with themechanostat also
have the potential to exert site-speciﬁc effects. Therefore, we used the
previously-described site-speciﬁcity analysis software, [18] to map the
effects of iPTH and loading on Ct.Ar, Tt.Ar and Ct.Th across the entire
length of bones from the six-week iPTH study (Fig. 7). Loading predom-
inantly increased Ct.Ar and Ct.Th site-speciﬁcally in the proximal 50% of
the tibia, with minimal effects on Tt.Ar in vehicle-treated mice. iPTH in-
creased Ct.Ar over the proximal 70% of the tibia while reducing Ct.Th in
the proximal 50%. Loading of iPTH-treated mice increased Tt.Ar and
Ct.Ar in sites within the proximal 30–50% of the tibia and also increasing
Ct.Th over the proximal 50% of the tibia. This implies that the effects of
combining iPTH and loading are additive across the proximal half of
the tibia in agreement with the ﬁnding at the 37% cortical site (Fig. 7).
4. Discussion
Although the mechanisms of action of PTH have been extensively
studied, the optimal experimental conditions to achieve maximum ef-
fects in mouse bones have not been reported. Thus in different studies,
different doses and durations of treatment are used and their effects at
different skeletal sites of interest analysed, making comparisons be-
tween studies difﬁcult. Here we report the effect of four doses and
two durations of treatment with iPTH alone and the effect of iPTH on
the response of aged rather than young bone to artiﬁcial loading. Our
Fig. 3.Micewere treatedwith vehicle or 50 μg/kg/day for 28 days and the effect on bone architecture examined using μCT (a) andﬂuorescent bone labels (b). Further sections of bonewere
stainedwithH&E (c) or immunostained for cathepsinK (d), sclerostin (e) or periostin (f). Large images are 10 times and insert images are 40 timesmagniﬁcation. Scale bars in large images
equals 100 μm and in insert images 50 μm. Osteoclasts were deﬁned as large, strongly cathepsin K stained cells on a bone surface and are indicated by arrows in ﬁgure d. Examples of
sclerostin positive osteocytes are indicated by arrows in ﬁgure e.
Fig. 4. The effect of iPTH on the load strain relationship. Tibial stiffness was unaffected by
treatment with iPTH.
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data show that in old mice responses to iPTH and loading differ in both
their individual and combined effects to thosewepreviously reported in
young mice [14].
Analysis of the effects of different doses of iPTH on cortical and tra-
becular bone in the tibia of aged mice demonstrated a dose-
dependent effect of iPTH on Tt.Ar and Ct.Ar. This was expected as iPTH
has previously been reported to be anabolic on both periosteal and end-
osteal surfaces of cortical bone in the distal femur [27]. In contrast, we
found no effect of iPTH alone on trabecular bone in the proximal tibia
despite being previously reported to be anabolic in the trabecular
bone of the L5 vertebra [27]. This may reﬂect the lower trabecular con-
tent of the proximal tibia in agedmice comparedwith the vertebrae. An
unexpected ﬁnding in the present study was the dramatic intra-cortical
remodelling observed in the tibial cortex, particularly with the higher
doses of iPTH in aged mice. To our knowledge, this ﬁnding has not
been reported with intermittent administration of PTH in mice despite
other studies using similar doses [14,27]. This difference could reﬂect
the different ages ofmice and sites of bone analysed. The result is similar
to the phenotype previously reported in the caPTH1R-Dmp1 mice
which was shown to exhibit periosteal and endosteal bone formation
withmarked increases in intracortical remodelling and cortical porosity
[28]. Although the PTH in our study was administered by daily subcuta-
neous injection, it is possible that the effects of PTH in aged mice are
prolonged leading to a phenotype more similar to that observed with
continuous activation of PTHR1.
The intracortical pore formation in the aged mice in our current
study appears to be a dynamic process, cathepsin K staining demon-
strating an inﬂux of osteoclasts in response to iPTH. This increased num-
ber of osteoclasts indicates that the resorption is by osteoclasts rather
than any other process such as osteocytic osteolysis [29] and is consis-
tent with PTH's known ability to stimulate bone resorption by enhanc-
ing osteoclastogenesis [30]. The presence of periostin-positive cells
within the pores and evidence of bone mineral deposition (from ﬂuo-
rescent labelling) indicates concomitant osteoblastic bone formation.
This suggests that iPTH may be stimulating simultaneous bone resorp-
tion and formation.
Fig. 5. The effect of 2- and 6-weeks of treatmentwith vehicle or 50 μg/kg/day iPTH on the response to loading for trabecular BV/TV (a), Tb.Th (b), Tb.N (c) and Tb.Sp (d). Representative 3D
reconstructions showing the effect of 6-weeks iPTH on the response to loading in the region of trabecular bone analysed by μCT (e-h). P-values represent results of the two-way repeated
measures ANOVA for the 2- and 6-week loading experiments for the effect of PTH, loading and their interaction. Signiﬁcant results are indicated in bold.
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We had expected from our previous study in young mice [14] that
iPTHwould interactwithmechanical loading resulting in proportionally
larger increases in bone mass and architecture than those previously
observed in aged mice [3]. Contrary to our expectation, in trabecular
bone iPTH abrogated some of the beneﬁcial effects of mechanical load-
ing; for example on BV/TV and trabecular number. The proximal tibia
of aged mice contains very few trabeculae and proportionally fewer
than bones such as the vertebra. Nevertheless, the response in aged
mice is different from that observed in youngmice using the same load-
ing model. This emphasises the importance of being careful when ex-
trapolating responses in young animals to those in old ones. This may
be particularly true in the case of PTH as we have recently reported
basal and loading-responsive transcriptomic differences between tibiae
of young and agedmice [31]. These includeWnt signalling and bioener-
getics processes, both of which are involved in the anabolic effects of
PTH [32,33].
In cortical bone, mechanical loading had the same beneﬁcial effects
as those previously reported such as a signiﬁcant increase in cortical
area and thickness [3,6]. Some of the potentially deleterious effects of
iPTH in cortical bone, such as the increase in intracortical porosity and
decrease in cortical thickness, were partially rescued by mechanical
loading. This is consistent with previously published data. For example,
genetic knock down of the BMP1Ra increases cortical porosity which is
partially rescued by increased exercise [34].
Fig. 6. The effect of 2- and 6-weeks of treatment with vehicle or 50 μg/kg/day iPTH on the response to loading for Tt.Ar (a), Ct.Ar (b), Ct.Th (c) and Ct.Po (d). Representative 3D
reconstructions showing the effect of 6-weeks iPTH on the response to loading in the region of cortical bone analysed by μCT (e-h). P-values represent results of the two-way repeated
measures ANOVA for the 2- and 6-week loading experiments for the effect of PTH, loading and their interaction. Signiﬁcant results are indicated in bold.
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Further elucidation of the different mechanisms of action of iPTH
and mechanical loading is likely to be informative. In young mice,
when iPTH and loading were combined there was a potentially syner-
gistic response suggesting some commonality, or at least complemen-
tarity, between the cellular mechanisms underlying the responses
[14]. Thiswe hypothesized to bemediated by sclerostin since both load-
ing and iPTH are known to result in its downregulation and therefore in-
creased Wnt signalling [11,24]. However, in aged mice although both
loading [3] and PTH (this study) cause sclerostin down-regulation
there does not appear to be any evidence of interaction between the
two responses in terms at least of (re)modelling. This is consistent
with a recent study showing that downregulation of Sost mRNA is re-
quired for the anabolic effects of loading, but not iPTH in young adult
mice [35]. Thus it may be that deﬁciencies in the responses of aged
mice to iPTH are either independent of sclerostin or occur down-
stream of its down-regulation, such as in the recruitment or prolifera-
tion of osteoblast cells [36]. The protein-level down-regulation of
sclerostin with iPTHwas sustained up to at least six weeks of treatment
in the present study, but this did not ‘rejuvenate’ the magnitude of
bone's adaptation to mechanical loading to levels expected in young
mice. This suggests that the age-related impairment of bone's adapta-
tion to loading is not entirely explained by more transient down-
regulation of sclerostin [37] impairing sustained Wnt signalling
activation.
Osteoblast recruitment and sclerostin regulation are site-speciﬁcally
inﬂuenced by loading [3,24], potentially-explaining the apparent re-
striction of osteogenic responses to axial loading to the proximal half
of the mouse tibia. The ability of the distal tibia to increase in mass is
demonstrated by the signiﬁcant increase in Ct.Ar below the tibia/ﬁbula
junction following iPTH treatment independently of loading, as identi-
ﬁed by site-speciﬁcity analysis. This analysis provides meaningful addi-
tional information and precludes overly-simplistic conclusions drawn
from analyses of individual sites. For example, if the main analyses of
this study had focused on the tibial mid-shaft (50% site), no response
to loading would have been observed and the response to PTH would
not have appeared meaningfully increased by loading. Site-speciﬁcity
analysis therefore represents an important experimental reﬁnement
that should prevent erroneous interpretations of experiments based
on results from single sites.
In summary, in agedmice there was only a small effect of iPTH alone
on trabecular bone, whichwas independent of dose although treatment
(50 μg/kg/day) for six weeks had a stronger effect than two weeks. In
trabecular bone, iPTH and loading have no positive interaction, indeed
iPTH appears to reduce the positive effects of loading on trabecular
number. In contrast, in cortical bone iPTH had a positive osteogenic
dose and time-dependent effect. However, in aged mice, unlike in
young ones, this effect appears to act independently from the osteogen-
ic effect of loading there being no interaction between the two. Thus the
positive interactions between the osteogenic effects of loading and iPTH
seen in young animals are not reproduced in old ones where they could
therapeutically be most useful. Indeed in trabecular bone the positive
interactions seen in young animals were replaced with negative ones
in old ones, iPTH inhibiting loading-induced increases in BV/TV. These
data reinforce the caution that must be exercised when extrapolating
from young populations to old ones.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bone.2017.02.009.
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